Role of Adenosine Deaminase in Patients with Erythematotelangiectatic Rosacea and
Adenosine deaminase level
Demodex folliculorum
Erythematotelangiectatic rosacea
Journal
Iranian journal of parasitology
ISSN: 1735-7020
Titre abrégé: Iran J Parasitol
Pays: Iran
ID NLM: 101464309
Informations de publication
Date de publication:
Historique:
entrez:
22
4
2021
pubmed:
23
4
2021
medline:
23
4
2021
Statut:
ppublish
Résumé
Adenosine deaminase (ADA) is an aminohydrolase involved in the catabolism of purine nucleotides and irreversibly deaminizes adenosine and deoxyadenosine to inosine and deoxyinosine. ADA enzyme deficiency results in the loss of functional properties of B and T lymphocytes. Serum ADA levels were examined for 30 patients diagnosed with erythematotelangiectatic rosacea and 40 healthy individuals in Malatya Inonu University in 2017. Standardized skin surface biopsy (SSSB) method was used to diagnose ADA levels were decreased in the During and after treatment of
Sections du résumé
BACKGROUND
BACKGROUND
Adenosine deaminase (ADA) is an aminohydrolase involved in the catabolism of purine nucleotides and irreversibly deaminizes adenosine and deoxyadenosine to inosine and deoxyinosine. ADA enzyme deficiency results in the loss of functional properties of B and T lymphocytes.
METHODS
METHODS
Serum ADA levels were examined for 30 patients diagnosed with erythematotelangiectatic rosacea and 40 healthy individuals in Malatya Inonu University in 2017. Standardized skin surface biopsy (SSSB) method was used to diagnose
RESULTS
RESULTS
ADA levels were decreased in the
CONCLUSION
CONCLUSIONS
During and after treatment of
Identifiants
pubmed: 33884017
doi: 10.18502/ijpa.v15i4.4870
pii: IJPA-15-596
pmc: PMC8039488
doi:
Types de publication
Journal Article
Langues
eng
Pagination
596-601Informations de copyright
Copyright © 2020 Sener et al. Published by Tehran University of Medical Sciences.
Déclaration de conflit d'intérêts
Conflict of interest The authors declare that there is no conflict of interest.
Références
Rev Inst Med Trop Sao Paulo. 2000 May-Jun;42(3):171-3
pubmed: 10887379
J Lab Clin Med. 1970 Sep;76(3):507-17
pubmed: 4318766
Clin Exp Dermatol. 2003 Jan;28(1):70-3
pubmed: 12558635
Acta Dermatovenerol Croat. 2003 Dec;11(4):236-46
pubmed: 14670225
Br J Dermatol. 2001 Jun;144(6):1121-6
pubmed: 11422030
Br J Dermatol. 2014 Jun;170(6):1219-25
pubmed: 24471456
Clin Rheumatol. 2001;20(6):411-6
pubmed: 11771524
Br J Dermatol. 1971 Feb;84(2):117-23
pubmed: 4100979
Int J Dermatol. 1998 Jun;37(6):421-5
pubmed: 9646125
J Am Acad Dermatol. 1982 Nov;7(5):583-9
pubmed: 7142466
Acta Derm Venereol. 2002;82(1):3-6
pubmed: 12013194
Indian J Dermatol. 2013 Mar;58(2):157
pubmed: 23716816
Br J Dermatol. 2001 Jan;144(1):139-42
pubmed: 11167695
Am J Dermatopathol. 1996 Dec;18(6):589-91
pubmed: 8989930
Dermatologica. 1981;162(1):1-11
pubmed: 6453029
Clin Chim Acta. 2008 Feb;388(1-2):135-8
pubmed: 18023276
J Med Microbiol. 2014 Feb;63(Pt 2):258-262
pubmed: 24248990
Clin Biochem. 2009 Sep;42(13-14):1438-43
pubmed: 19026999
Wiad Parazytol. 2005;51(3):253-6
pubmed: 16913532
Mediators Inflamm. 2003 Apr;12(2):107-16
pubmed: 12775361
Biochem Biophys Res Commun. 2000 Jun 7;272(2):311-5
pubmed: 10833410
Clin Dermatol. 2002 Mar-Apr;20(2):135-40
pubmed: 11973047
J Egypt Soc Parasitol. 2000 Dec;30(3):851-4
pubmed: 11198383
J Eur Acad Dermatol Venereol. 2004 Jul;18(4):440-4
pubmed: 15196158
Dan Med Bull. 1971 Feb;18(1):14-7
pubmed: 5110952
J Cutan Pathol. 1998 Nov;25(10):550-2
pubmed: 9870674
Lancet. 1972 Nov 18;2(7786):1067-9
pubmed: 4117384